|
[1]
|
Goel, A.R. and Yalcindag, A. (2025) An Update on Kawasaki Disease. Current Rheumatology Reports, 27, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jone, P., Tremoulet, A., Choueiter, N., Dominguez, S.R., Harahsheh, A.S., Mitani, Y., et al. (2024) Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Circulation, 150, e70267. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Nakamura, Y., Yashiro, M. and Yanagawa, H. (2025) Epidemiology of Kawasaki Disease in Japan in 2021-2022: Results of the 27th Nationwide Survey. Pediatrics International, 67, e70007. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Suzuki, A., Kamiya, T., Kuwahara, N., Ono, Y., Kohata, T., Takahashi, O., et al. (1986) Coronary Arterial Lesions of Kawasaki Disease: Cardiac Catheterization Findings of 1100 Cases. Pediatric Cardiology, 7, 3-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Jone, P., Tremoulet, A., Choueiter, N., Dominguez, S.R., Harahsheh, A.S., Mitani, Y., et al. (2025) Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Circulation, 151, e863.
|
|
[6]
|
Uehara, R. and Belay, E.D. (2012) Epidemiology of Kawasaki Disease in Asia, Europe, and the United States. Journal of Epidemiology, 22, 79-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Newburger, J.W., Sleeper, L.A., McCrindle, B.W., Minich, L.L., Gersony, W., Vetter, V.L., et al. (2007) Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease. New England Journal of Medicine, 356, 663-675. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
黄玉娟, 李夙凌, 田园, 等. 中国儿童川崎病诊疗循证指南(2023年) [J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210.
|
|
[9]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
|
[10]
|
McCrindle, B.W. (2009) Kawasaki Disease: A Childhood Disease with Important Consequences into Adulthood. Circulation, 120, 6-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lin, M. and Wu, M. (2018) The Global Epidemiology of Kawasaki Disease: Review and Future Perspectives. Global Cardiology Science and Practice, 2017, 1-6. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Singh, S., Vignesh, P. and Burgner, D. (2015) The Epidemiology of Kawasaki Disease: A Global Update. Archives of Disease in Childhood, 100, 1084-1088. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Watelle, L., Dahoud, A., Blais, S., Scuccimarri, R., Renaud, C., McCrindle, B.W., et al. (2025) Males with Kawasaki Disease Develop Coronary Artery Aneurysms More than Twice as Much as Females. Paediatrics & Child Health, 30, 250-256. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ramphul, K. and Mejias, S.G. (2018) Kawasaki Disease: A Comprehensive Review. Archives of Medical Science—Atherosclerotic Diseases, 3, 41-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Li, T., Feng, J., Li, N. and Liu, T. (2021) Correct Identification of Incomplete Kawasaki Disease. Journal of International Medical Research, 49, Article ID: 1001712. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Shafy, S.S.M., Salavarria, K.A.C., Saleh, S., Cuino, I., Nadeem, S., Perez, R.C.R., et al. (2025) Long-Term Outcomes of Coronary Artery Aneurysms in Children with Kawasaki Disease: A Systematic Review. Cureus, 17, e94418. [Google Scholar] [CrossRef]
|
|
[17]
|
Libby, P., Ridker, P.M. and Hansson, G.K. (2009) Inflammation in Atherosclerosis. Journal of the American College of Cardiology, 54, 2129-2138. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yoshikane, Y., Koga, M., Cho, T., Imanaka-Yoshida, K., Yamamoto, Y., Hashimoto, J., et al. (2016) Tissue Remodeling in Vascular Wall in Kawasaki Disease-Related Vasculitis Model Mice. In: Nakanishi, T., Markwald, R., Baldwin, H., Keller, B., Srivastava, D. and Yamagishi, H., Eds., Etiology and Morphogenesis of Congenital Heart Disease, Springer, 241-242. [Google Scholar] [CrossRef]
|
|
[19]
|
Jia, C., Zhang, J., Chen, H., Zhuge, Y., Chen, H., Qian, F., et al. (2019) Endothelial Cell Pyroptosis Plays an Important Role in Kawasaki Disease via HMGB1/RAGE/Cathespin B Signaling Pathway and NLRP3 Inflammasome Activation. Cell Death & Disease, 10, Article No. 778. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Hara, T. and Sakai, Y. (2025) The Etiopathogenesis of Kawasaki Disease: Evolving Understanding of Diverse Triggers. Immunity, Inflammation and Disease, 13, e70267. [Google Scholar] [CrossRef]
|
|
[21]
|
Paolini, L., Guida, F., Calvaruso, A., Andreozzi, L., Pierantoni, L., Lanari, M., et al. (2024) Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease. International Journal of Molecular Sciences, 25, Article 13322. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kumrah, R., Goyal, T., Rawat, A. and Singh, S. (2024) Markers of Endothelial Dysfunction in Kawasaki Disease: An Update. Clinical Reviews in Allergy & Immunology, 66, 99-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Qian, G., Wang, Y., Yao, H., Zhang, Z., Wang, W., Xu, L., et al. (2025) Involvement of USP7 in Aggravating Kawasaki Disease by Promoting TGFβ2 Signaling Mediated Endothelial-Mesenchymal Transition and Coronary Artery Remodeling. International Immunopharmacology, 146, Article ID: 113823. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Patra, P.K., Banday, A.Z., Das, R.R., Manohari, S., Jindal, A.K. and Singh, S. (2023) Long-Term Vascular Dysfunction in Kawasaki Disease: Systematic Review and Meta-Analyses. Cardiology in the Young, 33, 1614-1626. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Onouchi, Y., Gunji, T., Burns, J.C., Shimizu, C., Newburger, J.W., Yashiro, M., et al. (2008) ITPKC Functional Polymorphism Associated with Kawasaki Disease Susceptibility and Formation of Coronary Artery Aneurysms. Nature Genetics, 40, 35-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Khor, C.C., Davila, S., Breunis, W.B., Lee, Y., Shimizu, C., Wright, V.J., et al. (2011) Genome-Wide Association Study Identifies FCGR2A as a Susceptibility Locus for Kawasaki Disease. Nature Genetics, 43, 1241-1246. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Uehara, R., Yashiro, M., Nakamura, Y. and Yanagawa, H. (2003) Kawasaki Disease in Parents and Children. Acta Paediatrica, 92, 694-697. [Google Scholar] [CrossRef]
|
|
[28]
|
Dou, J. (2024) Relationship between Serum Plasminogen Activator and D-Dimer Levels and the Severity of Kawasaki Disease in Children as Well as Their Predictive Value for Coronary Artery Lesion. American Journal of Translational Research, 16, 3240-3247. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wang, W., Zhu, L., Li, X., Liu, Z., Lv, H. and Qian, G. (2023) Emerging Evidence of Microbial Infection in Causing Systematic Immune Vasculitis in Kawasaki Disease. Frontiers in Microbiology, 14, Article 1313838. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kobayashi, T., Ayusawa, M., Suzuki, H., Abe, J., Ito, S., Kato, T., et al. (2020) Revision of Diagnostic Guidelines for Kawasaki Disease (6th Revised Edition). Pediatrics International, 62, 1135-1138. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Yang, H., Du, Z. and Fu, P. (2013) Clinical Features of Recurrent Kawasaki Disease and Its Risk Factors. European Journal of Pediatrics, 172, 1641-1647. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Niu, L., An, X.J., Fu, M.Y., He, X.H. and Wang, Q.W. (2015) Observation of Kawasaki Disease-Related Indexes and the Study of Relationship between Myocardial Enzyme Changes and Coronary Artery Lesions. European Review for Medical and Pharmacological Sciences, 19, 4407-4410.
|
|
[33]
|
Mossberg, M., Mohammad, A.J., Kahn, F., Segelmark, M. and Kahn, R. (2021) High Risk of Coronary Artery Aneurysm in Kawasaki Disease. Rheumatology, 60, 1910-1914. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Patel, R.M. and Shulman, S.T. (2015) Kawasaki Disease: A Comprehensive Review of Treatment Options. Journal of Clinical Pharmacy and Therapeutics, 40, 620-625. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Conte, C., Sogni, F., Rigante, D. and Esposito, S. (2023) An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children. Diagnostics, 13, Article 1441. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
穆志龙, 焦富勇, 谢凯生.《川崎病心血管后遗症的诊断和管理指南(JCS/JSCS 2020)》解读[J]. 中国当代儿科杂志, 2021, 23(3): 213-220.
|
|
[37]
|
Maccora, I., Calabri, G.B., Favilli, S., Brambilla, A., Trapani, S., Marrani, E., et al. (2021) Long-Term Follow-Up of Coronary Artery Lesions in Children in Kawasaki Syndrome. European Journal of Pediatrics, 180, 271-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Liu, Y., Zhang, Y., Xie, Y., Li, W., Wei, H., Liu, L., et al. (2025) Risk Factors and Regression of Coronary Aneurysms in Infants with Kawasaki Disease. Cardiovascular Therapeutics, 2025, Article ID: 9988778. [Google Scholar] [CrossRef]
|
|
[39]
|
Kato, T., Miura, M., Kobayashi, T., et al. (2023) Analysis of Coronary Arterial Aneurysm Regression in Patients with Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression. Journal of the American Heart Association, 12, e022417.
|
|
[40]
|
Chen, Y., Yang, M., Zhang, M., Wang, H., Zheng, Y., Sun, R., et al. (2025) Single-cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 44, 866-882. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wang, S., Luo, G., Ji, Z. and Pan, S. (2025) No Causal Association between Gut Microbiota and Kawasaki Disease: A Two-Sample Mendelian Randomization Study. Pediatric Research, 98, 423-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Jena, P.K., Arditi, M. and Noval Rivas, M. (2025) Gut Microbiota Alterations in Patients with Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 45, 345-358. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Ferrara, G., Giani, T., Caparello, M.C., Farella, C., Gamalero, L. and Cimaz, R. (2020) Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review. Pediatric Drugs, 22, 645-652. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zeng, Y., Zhang, M., Ko, S. and Chen, F. (2021) An Update on Cardiovascular Risk Factors after Kawasaki Disease. Frontiers in Cardiovascular Medicine, 8, Article 671198. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Hara, T., Nakashima, Y., Sakai, Y., Nishio, H., Motomura, Y. and Yamasaki, S. (2016) Kawasaki Disease: A Matter of Innate Immunity. Clinical and Experimental Immunology, 186, 134-143. [Google Scholar] [CrossRef] [PubMed]
|